 Carolyn Welsh
Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchiolitis Obliterans | 2 | 2015 | 66 | 0.750 |
Why?
| | Societies, Medical | 2 | 2015 | 663 | 0.530 |
Why?
| | Lung Diseases | 4 | 2024 | 701 | 0.440 |
Why?
| | Lung Transplantation | 1 | 2015 | 246 | 0.410 |
Why?
| | Pulmonary Medicine | 2 | 2014 | 87 | 0.300 |
Why?
| | Venous Thrombosis | 2 | 2007 | 140 | 0.300 |
Why?
| | Hypercapnia | 1 | 2007 | 51 | 0.290 |
Why?
| | Systems Biology | 1 | 2007 | 54 | 0.270 |
Why?
| | Deoxycytidine | 1 | 2007 | 138 | 0.270 |
Why?
| | Palliative Care | 2 | 2024 | 641 | 0.250 |
Why?
| | Endotoxins | 4 | 1993 | 211 | 0.240 |
Why?
| | Syphilis, Cutaneous | 1 | 2004 | 2 | 0.240 |
Why?
| | Treponema pallidum | 1 | 2004 | 7 | 0.240 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2007 | 194 | 0.240 |
Why?
| | Pneumonia | 2 | 2007 | 567 | 0.220 |
Why?
| | Patient Care Team | 2 | 2024 | 517 | 0.190 |
Why?
| | Physician's Role | 1 | 2003 | 197 | 0.180 |
Why?
| | Pentoxifylline | 2 | 1991 | 21 | 0.170 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2024 | 913 | 0.170 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 1355 | 0.160 |
Why?
| | Heart Failure | 2 | 2024 | 1945 | 0.160 |
Why?
| | Lung Diseases, Interstitial | 2 | 2024 | 507 | 0.150 |
Why?
| | Telemedicine | 1 | 2024 | 662 | 0.130 |
Why?
| | Neutrophils | 4 | 1991 | 1176 | 0.130 |
Why?
| | Prazosin | 1 | 2015 | 24 | 0.120 |
Why?
| | Dreams | 1 | 2015 | 10 | 0.120 |
Why?
| | Capillary Permeability | 4 | 1993 | 135 | 0.120 |
Why?
| | Pneumonia, Mycoplasma | 1 | 1995 | 30 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2019 | 1213 | 0.110 |
Why?
| | Syndrome | 1 | 2015 | 333 | 0.110 |
Why?
| | Quality of Life | 2 | 2024 | 2353 | 0.100 |
Why?
| | Pulmonary Ventilation | 1 | 1993 | 72 | 0.100 |
Why?
| | Pulmonary Embolism | 3 | 1999 | 181 | 0.100 |
Why?
| | Salmonella enteritidis | 2 | 1989 | 16 | 0.100 |
Why?
| | Acclimatization | 1 | 1993 | 149 | 0.100 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 233 | 0.100 |
Why?
| | Respiratory Insufficiency | 1 | 1995 | 290 | 0.090 |
Why?
| | Pulmonary Circulation | 2 | 1993 | 407 | 0.090 |
Why?
| | Antibiotics, Antitubercular | 1 | 1991 | 34 | 0.090 |
Why?
| | Humans | 19 | 2024 | 114599 | 0.090 |
Why?
| | Gastrectomy | 1 | 1991 | 82 | 0.090 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1991 | 112 | 0.080 |
Why?
| | Lung | 6 | 1999 | 3557 | 0.080 |
Why?
| | Altitude | 1 | 1993 | 432 | 0.080 |
Why?
| | Theobromine | 1 | 1988 | 2 | 0.080 |
Why?
| | Pulmonary Artery | 2 | 1993 | 1015 | 0.080 |
Why?
| | Aging | 1 | 1998 | 1618 | 0.080 |
Why?
| | Blood Proteins | 2 | 1993 | 231 | 0.070 |
Why?
| | Mycobacterium tuberculosis | 1 | 1991 | 268 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 3 | 2004 | 2279 | 0.070 |
Why?
| | Diagnosis | 1 | 2007 | 9 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1394 | 0.070 |
Why?
| | Carboplatin | 1 | 2007 | 135 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2015 | 754 | 0.070 |
Why?
| | Male | 13 | 2024 | 55534 | 0.070 |
Why?
| | Single-Blind Method | 2 | 2024 | 258 | 0.070 |
Why?
| | Aged | 7 | 2024 | 19056 | 0.070 |
Why?
| | Asthma | 2 | 2014 | 2029 | 0.060 |
Why?
| | Dyspnea | 1 | 2007 | 211 | 0.060 |
Why?
| | Pulmonary Edema | 3 | 1993 | 115 | 0.060 |
Why?
| | Endothelium, Vascular | 1 | 1991 | 843 | 0.060 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2007 | 196 | 0.060 |
Why?
| | Risk | 1 | 2007 | 812 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2015 | 2127 | 0.060 |
Why?
| | Social Workers | 1 | 2024 | 32 | 0.060 |
Why?
| | Biopsy, Needle | 1 | 2004 | 182 | 0.060 |
Why?
| | Obesity | 2 | 2007 | 2507 | 0.060 |
Why?
| | Radiography, Thoracic | 1 | 2004 | 150 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2007 | 2537 | 0.050 |
Why?
| | Activated Protein C Resistance | 1 | 2003 | 2 | 0.050 |
Why?
| | Medical Laboratory Science | 1 | 2003 | 7 | 0.050 |
Why?
| | Factor V | 1 | 2003 | 22 | 0.050 |
Why?
| | Information Systems | 1 | 2003 | 61 | 0.050 |
Why?
| | Nurse's Role | 1 | 2024 | 106 | 0.050 |
Why?
| | Patient Readmission | 1 | 2007 | 608 | 0.050 |
Why?
| | Certification | 1 | 2003 | 89 | 0.050 |
Why?
| | Age Distribution | 1 | 2003 | 342 | 0.050 |
Why?
| | Sex Distribution | 1 | 2003 | 337 | 0.050 |
Why?
| | Canada | 1 | 2003 | 322 | 0.050 |
Why?
| | Workload | 1 | 2003 | 132 | 0.050 |
Why?
| | Nurses | 1 | 2024 | 145 | 0.050 |
Why?
| | Employment | 1 | 2003 | 137 | 0.050 |
Why?
| | Middle Aged | 7 | 2004 | 26705 | 0.050 |
Why?
| | Hypoxia | 1 | 2007 | 956 | 0.050 |
Why?
| | Needs Assessment | 1 | 2003 | 314 | 0.050 |
Why?
| | Terminal Care | 1 | 2024 | 213 | 0.040 |
Why?
| | Respiration, Artificial | 1 | 2004 | 529 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2024 | 478 | 0.040 |
Why?
| | Dogs | 3 | 1993 | 334 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1629 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2004 | 4411 | 0.040 |
Why?
| | Adult | 6 | 2024 | 30514 | 0.040 |
Why?
| | Snoring | 1 | 1998 | 12 | 0.040 |
Why?
| | Respiratory Muscles | 1 | 1998 | 28 | 0.040 |
Why?
| | Lung Diseases, Obstructive | 1 | 1998 | 40 | 0.040 |
Why?
| | Pulmonary Gas Exchange | 1 | 1998 | 117 | 0.040 |
Why?
| | Respiratory Mechanics | 1 | 1998 | 56 | 0.040 |
Why?
| | Carcinoma, Small Cell | 1 | 1998 | 158 | 0.040 |
Why?
| | Sleep Apnea Syndromes | 1 | 1998 | 74 | 0.040 |
Why?
| | Ventilation-Perfusion Ratio | 2 | 1998 | 9 | 0.040 |
Why?
| | Female | 8 | 2024 | 59446 | 0.040 |
Why?
| | Chronic Disease | 2 | 2019 | 1578 | 0.030 |
Why?
| | Advance Care Planning | 1 | 2019 | 197 | 0.030 |
Why?
| | Tuberculosis | 1 | 1998 | 241 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2003 | 975 | 0.030 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 1 | 2015 | 18 | 0.030 |
Why?
| | Physicians | 1 | 2003 | 772 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2003 | 2084 | 0.030 |
Why?
| | Maximal Midexpiratory Flow Rate | 1 | 1993 | 3 | 0.030 |
Why?
| | Sleep | 1 | 1998 | 631 | 0.030 |
Why?
| | Spirometry | 1 | 1993 | 224 | 0.030 |
Why?
| | Time Factors | 2 | 2015 | 6112 | 0.030 |
Why?
| | Vital Capacity | 1 | 1993 | 255 | 0.030 |
Why?
| | Proteins | 2 | 1989 | 908 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 1993 | 475 | 0.020 |
Why?
| | Coronary Vessels | 1 | 1993 | 227 | 0.020 |
Why?
| | Chromium Radioisotopes | 1 | 1991 | 3 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2003 | 4618 | 0.020 |
Why?
| | Prognosis | 1 | 1998 | 3327 | 0.020 |
Why?
| | Drug Resistance, Microbial | 1 | 1991 | 66 | 0.020 |
Why?
| | Permeability | 1 | 1991 | 149 | 0.020 |
Why?
| | Vascular Surgical Procedures | 1 | 1993 | 259 | 0.020 |
Why?
| | Albumins | 1 | 1991 | 89 | 0.020 |
Why?
| | Radiography | 1 | 1993 | 812 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 1998 | 961 | 0.020 |
Why?
| | Intestinal Absorption | 1 | 1991 | 93 | 0.020 |
Why?
| | Cyclic AMP | 1 | 1991 | 227 | 0.020 |
Why?
| | Treatment Outcome | 3 | 2015 | 9084 | 0.020 |
Why?
| | Antitubercular Agents | 1 | 1991 | 169 | 0.020 |
Why?
| | Complement C5 | 1 | 1989 | 73 | 0.020 |
Why?
| | Radionuclide Imaging | 2 | 1999 | 115 | 0.020 |
Why?
| | Predictive Value of Tests | 2 | 2007 | 1796 | 0.020 |
Why?
| | Exercise | 1 | 1998 | 1644 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1993 | 1139 | 0.020 |
Why?
| | Cattle | 1 | 1991 | 920 | 0.020 |
Why?
| | Neutropenia | 1 | 1988 | 125 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 1991 | 951 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1987 | 106 | 0.020 |
Why?
| | Hemodynamics | 2 | 1988 | 1012 | 0.020 |
Why?
| | Blood Pressure | 1 | 1993 | 1538 | 0.020 |
Why?
| | United States | 1 | 2003 | 12167 | 0.020 |
Why?
| | Animals | 5 | 1993 | 31692 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 1998 | 2177 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2007 | 1075 | 0.010 |
Why?
| | Survival Analysis | 1 | 2007 | 1211 | 0.010 |
Why?
| | Tidal Volume | 1 | 2004 | 75 | 0.010 |
Why?
| | Myocardium | 1 | 1988 | 913 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1991 | 3881 | 0.010 |
Why?
| | Comorbidity | 1 | 2007 | 1448 | 0.010 |
Why?
| | Factor VIII | 1 | 2003 | 53 | 0.010 |
Why?
| | Blood Coagulation Tests | 1 | 2003 | 57 | 0.010 |
Why?
| | Sex Factors | 1 | 2007 | 1715 | 0.010 |
Why?
| | Risk Factors | 2 | 2007 | 8624 | 0.010 |
Why?
| | Kidney | 1 | 1988 | 1187 | 0.010 |
Why?
| | Regression Analysis | 1 | 2004 | 944 | 0.010 |
Why?
| | Child, Preschool | 1 | 1995 | 9106 | 0.010 |
Why?
| | Haplotypes | 1 | 2003 | 448 | 0.010 |
Why?
| | Genome, Human | 1 | 2003 | 347 | 0.010 |
Why?
| | Age Factors | 1 | 2007 | 2893 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2003 | 610 | 0.010 |
Why?
| | False Negative Reactions | 1 | 1999 | 48 | 0.010 |
Why?
| | Critical Illness | 1 | 2004 | 644 | 0.010 |
Why?
| | Iothalamate Meglumine | 1 | 1998 | 4 | 0.010 |
Why?
| | Technetium Tc 99m Aggregated Albumin | 1 | 1998 | 6 | 0.010 |
Why?
| | Iohexol | 1 | 1998 | 16 | 0.010 |
Why?
| | Angiography, Digital Subtraction | 1 | 1998 | 44 | 0.010 |
Why?
| | Reference Standards | 1 | 1998 | 159 | 0.010 |
Why?
| | Colorado | 1 | 2007 | 4099 | 0.010 |
Why?
| | Aged, 80 and over | 2 | 1999 | 6344 | 0.010 |
Why?
| | Radiopharmaceuticals | 1 | 1998 | 157 | 0.010 |
Why?
| | Angiography | 1 | 1998 | 174 | 0.010 |
Why?
| | Prospective Studies | 2 | 1999 | 6214 | 0.010 |
Why?
| | Probability | 1 | 1998 | 289 | 0.010 |
Why?
| | Adolescent | 1 | 1995 | 17827 | 0.010 |
Why?
| | Veterans | 1 | 2007 | 1237 | 0.010 |
Why?
| | Body Mass Index | 1 | 2004 | 1956 | 0.010 |
Why?
| | DNA | 1 | 2003 | 1351 | 0.010 |
Why?
| | Child | 1 | 1995 | 18401 | 0.010 |
Why?
| | Ultrasonography | 1 | 1999 | 633 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2003 | 3001 | 0.010 |
Why?
| | Contrast Media | 1 | 1998 | 345 | 0.010 |
Why?
| | Acute Disease | 1 | 1998 | 910 | 0.010 |
Why?
| | Anticoagulants | 1 | 1999 | 550 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1998 | 682 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 1998 | 1691 | 0.010 |
Why?
| | Oxygenators | 1 | 1993 | 4 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1999 | 2761 | 0.010 |
Why?
| | Blood Vessels | 1 | 1993 | 180 | 0.010 |
Why?
| | Complement System Proteins | 1 | 1993 | 282 | 0.010 |
Why?
| | Quinidine | 1 | 1987 | 6 | 0.000 |
Why?
| | Procainamide | 1 | 1987 | 5 | 0.000 |
Why?
| | Thiourea | 1 | 1987 | 39 | 0.000 |
Why?
| | Lidocaine | 1 | 1987 | 40 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1987 | 362 | 0.000 |
Why?
| | Organ Size | 1 | 1987 | 434 | 0.000 |
Why?
| | Hydrogen Peroxide | 1 | 1987 | 288 | 0.000 |
Why?
| | In Vitro Techniques | 1 | 1987 | 1016 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1999 | 12541 | 0.000 |
Why?
| | Rats | 1 | 1987 | 4958 | 0.000 |
Why?
|
|
Welsh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|